Getting a deal done, Beyond Air to sell NeuroNOS stake to Univo

Beyond Air, Inc. (XAIR) has entered into a definitive agreement to sell its stake in NeuroNOS Israel Ltd. to UNIVO Pharmaceutical Industries Ltd. (UNVO), a publicly traded Israeli company, according to a press release issued Aug. 25, 2026.

Under the terms of the deal, UNIVO will acquire NeuroNOS Limited, a wholly owned Irish subsidiary of Beyond Air that holds approximately 58% of NeuroNOS’s issued share capital on a fully diluted basis, representing 5,000,000 ordinary shares.

In exchange, Beyond Air will receive UNIVO ordinary shares representing 19.99% of UNIVO’s issued and outstanding share capital, along with warrants to purchase additional UNIVO ordinary shares representing 19.99% of UNIVO’s total outstanding options, warrants, and other awards, exercisable at $0.01 per share for five years following closing.